|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INCARA PHARMACEUTICALS CORP, 10-Q, 2000-07-28 |
Next: ACT MANUFACTURING INC, S-3/A, 2000-07-28 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND THE CONSOLIDATED STATEMENT OF INCOME FILED AS
PART OF THE QUARTERLY REPORT ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH QUARTERLY REPORT ON FORM 10-Q.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> JUN-30-2000
<CASH> 8,644
<SECURITIES> 0
<RECEIVABLES> 245
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 9,120
<PP&E> 189
<DEPRECIATION> 0
<TOTAL-ASSETS> 9,309
<CURRENT-LIABILITIES> 2,419
<BONDS> 48
0
0
<COMMON> 7
<OTHER-SE> 6,835
<TOTAL-LIABILITY-AND-EQUITY> 9,309
<SALES> 0
<TOTAL-REVENUES> 100
<CGS> 0
<TOTAL-COSTS> 14,619
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (4,481)
<INCOME-TAX> 0
<INCOME-CONTINUING> (4,481)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,481)
<EPS-BASIC> (0.75)<F1>
<EPS-DILUTED> (0.75)<F1>
<FN>
<F1>EPS BASIC
</FN>
</TABLE>
|
|